Breast Cancer News and Research

Latest Breast Cancer News and Research

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital ("PUCH"), Beijing, China.

9 Feb 2011

Study estimates 1.3 million cancer deaths in Europe in 2011

There will be nearly 1.3 million deaths from cancer in Europe in 2011 according to predictions from a study published in the cancer journal, Annals of Oncology today.

8 Feb 2011

More than 6% of bowel cancer patients in Scotland died within 30 days of diagnosis

More than six per cent of bowel cancer patients in Scotland died within 30 days of diagnosis according to new research published in the British Journal of Cancer.

8 Feb 2011

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Dots, LLC announced today that it will donate $91,086 to Susan G. Komen for the Cure to help fund ground-breaking research and life-saving community outreach projects through the "Girlfriends Giving Back" partnership program.

8 Feb 2011

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

For state governments, the bill presents huge new costs, as we are required to enroll 15 million to 20 million more people in our Medicaid systems. ... Perhaps worse, the law expects to conscript the states as its agents in its takeover of health care. It assumes that we will set up and operate its new insurance "exchanges" for it (Indiana Gov. Mitch Daniels, 2/7).

7 Feb 2011

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

EpiCept Corporation today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy. EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

7 Feb 2011

Studies show growing problems of non-communicable diseases in low-, middle-income countries

Obesity rates have doubled worldwide since 1980," according to a study published Friday as part of a series in the Lancet that also looked at global blood pressure and cholesterol trends, ABC News reports (Carolo, 2/4).

5 Feb 2011

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

5 Feb 2011

Physicians reaction to FDA decision to rescind breast cancer indication from Avastin

Sermo, the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.

5 Feb 2011

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

EntreMed, Inc., today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor. The clinical data were published in the December 3, 2010 on-line issue of the American Association for Cancer Research journal, Clinical Cancer Research, and are expected to appear soon in the print version of the publication.

4 Feb 2011

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva.

From Hologic, Inc. 4 Feb 2011

Merck reports GAAP net income of $861 million for 2010

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses.

4 Feb 2011

American Cancer Society report released on World Cancer Day

A new American Cancer Society report says cancers associated with lifestyles and behaviors related to economic development, including lung, breast, and colorectal cancers, will continue to rise in developing countries if preventive measures are not widely applied. The finding comes from the second edition of Global Cancer Facts & Figures and its academic publication, Global Cancer Statistics, published in CA: A Cancer Journal for Clinicians.

4 Feb 2011

More needs to be done globally to fight cancer

WHILE cancer statistics for the last 10 years make encouraging reading, more needs to be done globally to fight the killer disease.

4 Feb 2011

New study provides insight into mechanism behind breast cancer mutation

A new study sheds light on why individuals who inherit a particular family of mutations have a high risk of developing a very aggressive form of breast cancer. The research, published by Cell Press on February 4th in the journal Cell Stem Cell, shows that breast tissue cells from these individuals make abnormal cell-fate decisions even before cancer develops and provides exciting new insights into the mechanisms behind one of the most lethal types of breast cancer.

4 Feb 2011

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

Generex Biotechnology Corporation, together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, announced today that Antigen Express has received a Notice of Allowance from the United States Patent Office relating to an application making augmentative pharmaceutical composition claims for the Antigen Express AE37 immunotherapeutic cancer vaccine.

4 Feb 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Study estimates 1.3 million cancer deaths in Europe in 2011

More than 6% of bowel cancer patients in Scotland died within 30 days of diagnosis

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Viewpoints: (Still) Debating health law's constitutionality; Food labels; Lawmakers' abortion divide

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Studies show growing problems of non-communicable diseases in low-, middle-income countries

Patients receiving cancer treatment may experience skin, hair, nail problems

Physicians reaction to FDA decision to rescind breast cancer indication from Avastin

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Merck reports GAAP net income of $861 million for 2010

American Cancer Society report released on World Cancer Day

More needs to be done globally to fight cancer

New study provides insight into mechanism behind breast cancer mutation

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

Women's risk of getting breast cancer increases from one in nine to one in eight

Scientists unravel mystery about how new tumors in individuals with breast cancer take root

New concrete actions on cancer prevention in Europe

Study reveals how MMSET gene enables disease-causing mutations to occur

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in